Beyond the Deal: Regulatory, Competition and Transaction-Structuring Challenges in Cross-Border M&A in India
This Blog is Written by Jia Singh, 4th Year, BBA LLB (Hons), Amity University, Jharkhand.
Blog 20 | Edition VII
Introduction
— Cross-Border M&A Beyond Commercial Deal-Making
Most
often, cross-border mergers and acquisitions (M&A) are seen as business
transactions that are conducted through valuation, raising capital and
strategic expansion. But in India, the cross-border transaction is completed
through a multi-layered regulatory structure. Foreign exchange controls,
restrictions on foreign direct investment (FDI), merger control, securities
regulation and sector-specific approvals and corporate law provisions can be in
effect at the same time. The lawfulness of an acquisition thus cannot be judged
from the documents of the transaction alone. The Regulatory strategy should be
integrated into the design of the transaction. The article discusses how the
interplay between transaction structuring, FEMA/FDI compliance, competition law
and due diligence and contractual risk allocation affect the possibility of a
cross-border M&A transaction closing with reasonable legal certainty.
The Transaction Structuring (How to Do it): M&A Routes
There
are various legal implications in deciding to acquire shares, assets or to
merge. A share acquisition will usually retain the target's identity and
contracts, licences and liabilities, but will also introduce historical
liabilities for the acquirer. A greater degree of selectivity may be allowed
under an asset acquisition, but this can call for individual transfers,
consents and approvals for contracts, licences and intellectual property. The
amalgamation or merger develops a more unified system of restructuring. Section
234 of the Companies Act, 2013 allows a foreign company to merge with an Indian
company or vice versa with conditions as per the various provisions of the
Companies Act, 2013 after securing RBI approval. Therefore, rather than just
choosing structure for commercial convenience, regulatory approvals, tax
implications, liabilities and change of control restrictions and transfer of
assets and licences must be considered.
FEMA and FDI Compliance: The First Hurdle in the Regulatory Path is FEMA and FDI Compliance
The
Foreign Exchange Management Act, 1999 (FEMA) and Foreign Exchange Management
(Non-Debt Instruments) Rules, 2019 are the foundation regulatory provisions for
an FDI investor in Indian business. Foreign investment is governed by RBI's
Foreign Investment Master Direction and the NDI Rules and relevant regulations.
The investor is required to verify whether the investment is to be under the
automatic route or government route, whether foreign investment is allowed in
the specific sector, whether any sectoral cap or other conditions exist. In
particular, industries like banking, insurance, telecommunications and defence
require special care. The two are equally significant – pricing norms and
reporting obligations. There may be filings under FC-GPR or FC-TRS depending on
the nature of the transaction and periodical filings may be required under FLA.
The RBI gives guidelines on the time limits for the reporting of foreign
investment transactions. There are consequences to non-compliance, which can go
beyond monetary fines. There might be delays in the transaction, objections to
the transaction by regulators, problems in repatriation or restructuring of the
proposed investment. In this case, analysis of the FEMA should start at the
term-sheet phase, not after signing of the contract.
Managing Risk in Merger Control: Competition Law and CCI Approval
The merger control
regime in India may apply to a cross-border transaction even when the acquirer
is not incorporated in India. The terms
acquisition, merger, amalgamation and combinations are used in the Competition
Act, 2002 in respect of which an acquisition, a merger or an amalgamation which
meets the prescribed jurisdictional thresholds may be deemed as a
“combinations”, and such combinations must be notified to Competition
Commission of India (CCI) under Acts 5 and 6 of the Act. The CCI has the authority to alter or bar a combination
that it considers to have created and/or will create an Appreciable Adverse
Effect on Competition (AAEC). The modern
framework also takes into account the thresholds for deals, especially in cases
where the business acquired is valuable and the assets or the turnover are
relatively small in the Indian context. On notification and exemptions, the
framework of 2024 also added specific guidelines. The
CCI evaluates the factors covered under Section 20(4) such as Market Concentration,
Entry barriers, Countervailing power, Imports, Substitutes and chances of
elimination of an effective competitor. Most
importantly, India's merger-control regime is suspensory. Section 6(2A) restricts implementation of the combination
before the statutory approval or before the end of the period of time fixed by
the rule. If implemented early, it could
constitute "gun jumping" and could incur penalties.
Emirates NBD and RBL Bank Signed a Recent Agreement
The
deal with Emirates NBD Bank (P.J.S.C.) to acquire a majority stake in RBL Bank
illustrates how multiple regulatory jurisdictions can come together in a single
cross border transaction. CCI has approved the proposed acquisition in January
2026. The structure comprised preferential allotment of up to 60% of RBL's
shares; an open offer under the SEBI (Substantial Acquisition of Shares and
Takeovers) Regulations, 2011 of up to 26% of the Bank's shares, and proposed
amalgamation of Emirates NBD's Indian banking operations with RBL Bank. The transaction finally went through all the
necessary governmental and regulatory approvals and closed in June 2026,
whereby Emirates NBD acquired 60% of RBL's expanded share capital. This
transaction demonstrates that, in addition to one regulatory approval,
coordination between CCI, RBI, Government and SEBI is required in respect of
cross-border M&A.
Knowing What One is Getting Into and Handling Regulatory Risk through Contractual Allocation
The
regulatory due diligence should uncover license, foreign investment
restrictions, pending proceedings, change of control clauses, regulatory
correspondence and historical compliance issues. Where there is a listed
target, there is the need to do a take over regulation analysis as acquisition
of shares/control may give rise to obligations under open offer. SEBI
understand that there may be instances where shares are acquired directly as
well as indirectly, which could give rise to takeover requirements. Representations
and warranties, indemnities, conditions precedent and covenants should thus be
written to allocate regulatory risks in the acquisition agreement. In the
absence of legal requirements, regulatory approvals should be considered
conditions precedent to the closing. Long-stop dates should give enough time to
gain approvals and termination rights, deal with prolonged regulatory
uncertainty.
Laying the Groundwork for Regulatory Approvals and Deal Certainty: Building Regulatory Approvals and Deal Certainty
The
failure to regulate can have a material impact on valuation and financing
assumptions. Parties
should consequently adopt an approval time frame and assign responsibility for
filing and, to make sure, any additional regulatory requirements, the long-stop
dates and carefully crafted termination provisions become even more critical,
where multiple regulators are required to approve different elements of the
same transaction. It is also possible to negotiate
for a material adverse change clause that is not too broad to include routine
regulatory delays as a termination cause. Introducing
New Regulatory Hurdles in Cross-Border M&A. New Regulatory Hurdles in
Cross-Border M&A. Data, technology and
digital-market issues are more and more impacting cross-border M&A. Sensitive personal data, critical technology or highly
regulated businesses may be the subject of scrutiny in addition to the usual
merger-control analysis. The deal-value
threshold also reflects the regulator's growing competence in examining deals
with a competitive value that may not be evident in the conventional
asset/turnover metrics.
Concluding with Building Regulatory Certainty into M&A Transactions
The signing of the definitive
agreement is not the final step in a cross-border M&A transaction in India.
The success hinges on the legality of the transaction's legal structure to meet
India's foreign-exchange, corporate, competition, securities and sectoral
regulatory regimen. The investment must be compliant with FEMA and FDI
regulations for it to be able to enter the Indian market, it must be compliant
with competition law to be able to go through without the need to set up an
AAEC and contractual mechanisms will determine how regulatory uncertainty is
shared between the parties. The important conclusion is regulatory compliance
shouldn't be the final hurdle. It should be built in from the ground up –
transaction strategy. In complex cross-border M&A, regulatory planning is
not just about defense, it's about being an integral part of the deal.
(Write to the author at singhjia044@gmail.com.)

Comments
Post a Comment